Hideaki Suna

499 total citations
11 papers, 384 citations indexed

About

Hideaki Suna is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Hideaki Suna has authored 11 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Hideaki Suna's work include Marine Sponges and Natural Products (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Hideaki Suna is often cited by papers focused on Marine Sponges and Natural Products (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Hideaki Suna collaborates with scholars based in Japan, Indonesia and United Kingdom. Hideaki Suna's co-authors include Motomasa Kobayashi, Shunji Aoki, Andi Setiawan, Masayoshi Arai, Kei Muro, Hiroyoshi Nishikawa, Hiroshi Ishii, Tetsuyoshi Kawakami, Takahiro Tsushima and Toshihiko Doi and has published in prestigious journals such as Clinical Cancer Research, Biochemical and Biophysical Research Communications and Neuropharmacology.

In The Last Decade

Hideaki Suna

10 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideaki Suna Japan	9	143	114	93	92	80	11	384
Daniela Divlianska United States	10	60 0.4×	72 0.6×	155 1.7×	98 1.1×	60 0.8×	12	324
Qiuming Pan China	7	55 0.4×	96 0.8×	268 2.9×	90 1.0×	30 0.4×	10	402
Daniel Ayude Spain	13	193 1.3×	36 0.3×	202 2.2×	52 0.6×	36 0.5×	17	416
S. Djahansouzi Germany	9	114 0.8×	68 0.6×	117 1.3×	26 0.3×	22 0.3×	16	377
Toshihiro Chikanishi Japan	10	37 0.3×	80 0.7×	337 3.6×	104 1.1×	22 0.3×	12	504
I. Mayer Austria	8	92 0.6×	91 0.8×	166 1.8×	25 0.3×	27 0.3×	12	359
Xinxian Weng China	9	97 0.7×	51 0.4×	165 1.8×	25 0.3×	14 0.2×	14	306
Laura Biddick United States	12	91 0.6×	45 0.4×	189 2.0×	21 0.2×	15 0.2×	24	338
Michela Spinelli Italy	9	127 0.9×	68 0.6×	167 1.8×	16 0.2×	16 0.2×	15	335
Jianping Chen China	11	205 1.4×	68 0.6×	253 2.7×	18 0.2×	15 0.2×	20	451

Countries citing papers authored by Hideaki Suna

Since Specialization

Citations

This map shows the geographic impact of Hideaki Suna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Suna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Suna more than expected).

Fields of papers citing papers by Hideaki Suna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Suna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Suna. The network helps show where Hideaki Suna may publish in the future.

Co-authorship network of co-authors of Hideaki Suna

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Suna. A scholar is included among the top collaborators of Hideaki Suna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Suna. Hideaki Suna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Shitara, Kohei, Motohiro Tamiya, Kyoichi Okishio, et al.. (2025). Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1–Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study. Cancer Research Communications. 5(10). 1809–1820.

Hasegawa, Hirotaka, Kohei Shitara, Shuji Takiguchi, et al.. (2022). A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer. Gastric Cancer. 25(3). 619–628. 28 indexed citations

Ikeda, Masafumi, Takuji Okusaka, Izumi Ohno, et al.. (2021). Phase I Studies of Peptide Vaccine Cocktails Derived from GPC3, WDRPUH and NEIL3 for Advanced Hepatocellular Carcinoma. Immunotherapy. 13(5). 371–385. 18 indexed citations

Doi, Toshihiko, Kei Muro, Hiroshi Ishii, et al.. (2019). A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors. Clinical Cancer Research. 25(22). 6614–6622. 124 indexed citations

Machida, Kentaro, Tomotaka Kawayama, Masaharu Kinoshita, et al.. (2019). <p>Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial</p>. International Journal of COPD. Volume 14. 2175–2184. 1 indexed citations

Kawahara, Yuji, Noriko Morimoto, Masashi Kato, et al.. (2015). Anti-stress effects of ONO-2952, a novel translocator protein 18 kDa antagonist, in rats. Neuropharmacology. 99. 51–66. 18 indexed citations

Suna, Hideaki, et al.. (2009). Dysideamine, a new sesquiterpene aminoquinone, protects hippocampal neuronal cells against iodoacetic acid-induced cell death. Bioorganic & Medicinal Chemistry. 17(11). 3968–3972. 24 indexed citations

Aoki, Shunji, Yasuo Watanabe, D. Tanabe, et al.. (2007). Structure–activity relationship and biological property of cortistatins, anti-angiogenic spongean steroidal alkaloids. Bioorganic & Medicinal Chemistry. 15(21). 6758–6762. 79 indexed citations

Suna, Hideaki, Shunji Aoki, Andi Setiawan, & Motomasa Kobayashi. (2007). Crambescidin 800, a pentacyclic guanidine alkaloid, protects a mouse hippocampal cell line against glutamate-induced oxidative stress. Journal of Natural Medicines. 61(3). 288–295. 25 indexed citations

10.

Aoki, Shunji, Dexin Kong, Hideaki Suna, et al.. (2006). Aaptamine, a spongean alkaloid, activates p21 promoter in a p53-independent manner. Biochemical and Biophysical Research Communications. 342(1). 101–106. 56 indexed citations

11.

Suna, Hideaki, et al.. (2003). Elevation of serum acid phosphatase in Gaucher's disease.. PubMed. 23(2). 227–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact